Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Zenith Drugs Ltd
Zenith Drugs Ltd

Zenith Drugs Ltd (ZENITHDRUG) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 5,600
Dec 05, 2025
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹55.10
₹0.50 (0.92%)
55.00Low
Today’s Performance
55.10High
47.15Low
52 Week’s Performance
107.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-%
  • 1 Week0.73%
  • 1 Month-11.13%
  • 3 Months-21.23%
  • 6 Months-19.03%
  • 1 Year-38.19%
  • 3 Years-%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.74
  • 52-Week Low (₹)47.15
  • 52-Week High (₹)107.00
  • Price-to-Book (X)*1.36
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*13.18
  • Earnings Per Share (₹)4.18
  • Market Cap (₹ Cr.)*94.49
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Zenith Drugs Ltd share price previously?
Zenith Drugs Ltd share price was up by 0.92% from the previous closing price of ₹54.60.
Who are peers of Zenith Drugs Ltd?
The peers of Zenith Drugs Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Zenith Drugs Ltd?
The promotor/promotors of Zenith Drugs Ltd are Sandeep Bhardwaj, Bhupesh Soni, Ajay Singh Dassundi, Anil Malik, Ranjana Sureshkumar Sehgal, Deendayal Kumawat, Sakshi Bhawsar.
What has been 52-week high of Zenith Drugs Ltd stocks?
The highest price of Zenith Drugs Ltd stock is ₹107.00 in the last 52-week.
What is the share price of Zenith Drugs Ltd (ZENITHDRUG) today on NSE?
As on Dec 05, 2025 Zenith Drugs Ltd (ZENITHDRUG)’s share price on NSE is Rs 55.1
What is the market cap of Zenith Drugs Ltd (ZENITHDRUG)?
The current market capitalisation of Zenith Drugs Ltd (ZENITHDRUG) is 94.49 crores
What is Zenith Drugs Ltd Share symbol?
The symbol of Zenith Drugs Ltd is ZENITHDRUG.
What is the PE ratio of Zenith Drugs Ltd (ZENITHDRUG)?
The current PE ratio of Zenith Drugs Ltd (ZENITHDRUG) is 13.18.
What is the PB ratio of Zenith Drugs Ltd (ZENITHDRUG)?
The current PB ratio of Zenith Drugs Ltd (ZENITHDRUG) is 1.36.
Today’s High & Low share prices of Zenith Drugs Ltd (ZENITHDRUG) on NSE?
Today, the share price of Zenith Drugs Ltd (ZENITHDRUG) on NSE touched a high of Rs 55.1 and a low of Rs 55
What price did Zenith Drugs Ltd (ZENITHDRUG) shares open on the NSE today?
On NSE, the share price of Zenith Drugs Ltd (ZENITHDRUG) opened at Rs 55
What is the 52-week high of Zenith Drugs Ltd (ZENITHDRUG)?
The 52-week high price of Zenith Drugs Ltd (ZENITHDRUG) is Rs 107.00
What is the 52-week low of Zenith Drugs Ltd (ZENITHDRUG)?
The 52-week low price of Zenith Drugs Ltd (ZENITHDRUG) is Rs 47.15

bt_logoAbout Zenith

Zenith Drugs Ltd, incorporated in the year 2000, has its registered office in K # 72/5 Village Muradpura, NA Depalpur, Indore, Madhya Pradesh, 453001, +91 84355 01867. The main industry in which Zenith Drugs Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Zenith Drugs Ltd is/are VDS & Co. In the main management, is chairman and Sakshi Bhawsar is the company secretary for Zenith Drugs Ltd.

  • SB
    Sandeep BhardwajManaging Director & CFO
  • BS
    Bhupesh SoniExecutive Director
  • ASD
    Ajay Singh DassundiExecutive Director
  • AM
    Anil MalikNon Executive Director
  • RSS
    Ranjana Sureshkumar SehgalIndependent Director
  • DK
    Deendayal KumawatIndependent Director
  • SB
    Sakshi BhawsarCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.